RCL1
RNA 3'-terminal phosphate cyclase-like protein
Also known as: RCL1_HUMAN, RNAC, RPCL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2P8
- Gene
- RCL1
- Ensembl
- ENSG00000120158
- Chromosome
- 9
- Canonical length
- 373 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable RNA endonuclease activity. Involved in ribosomal small subunit biogenesis. Part of small-subunit processome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
373 residues, UniProt reviewed canonical sequence.
>Q9Y2P8|RCL1
1 MATQAHSLSY AGCNFLRQRL VLSTLSGRPV KIRKIRARDD NPGLRDFEAS FIRLLDKITN
61 GSRIEINQTG TTLYYQPGLL YGGSVEHDCS VLRGIGYYLE SLLCLAPFMK HPLKIVLRGV
121 TNDQVDPSVD VLKATALPLL KQFGIDGESF ELKIVRRGMP PGGGGEVVFS CPVRKVLKPI
181 QLTDPGKIKR IRGMAYSVRV SPQMANRIVD SARSILNKFI PDIYIYTDHM KGVNSGKSPG
241 FGLSLVAETT SGTFLSAELA SNPQGQGAAV LPEDLGRNCA RLLLEEIYRG GCVDSTNQSL
301 ALLLMTLGQQ DVSKVLLGPL SPYTIEFLRH LKSFFQIMFK IETKPCGEEL KGGDKVLMTC
361 VGIGFSNLSK TLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RCL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 229 nTPM
Expression across tissuesHPA
Tissue
- liver: 229 nTPM
- pancreas: 59 nTPM
- bone marrow: 42 nTPM
- adipose tissue: 35 nTPM
- blood vessel: 23 nTPM
- breast: 22 nTPM
Single-cell type
- hepatocytes: 318 nCPM
- pancreatic acinar cells: 265 nCPM
- myonuclei: 265 nCPM
- erythrocyte progenitors: 223 nCPM
- adipocytes: 139 nCPM
- leydig cells: 123 nCPM
Immune cell
- basophil: 16 nTPM
- NK-cell: 12 nTPM
- naive B-cell: 12 nTPM
- naive CD8 T-cell: 9 nTPM
- memory B-cell: 8.7 nTPM
- naive CD4 T-cell: 8.7 nTPM
Brain region
- white matter: 27 nTPM
- medulla oblongata: 25 nTPM
- spinal cord: 25 nTPM
- choroid plexus: 24 nTPM
- hypothalamus: 24 nTPM
- midbrain: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RCL1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 80 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Psychotic disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.06
- gnomAD missense Z
- -1.05
- DepMap mean gene effect
- -1.16
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
- endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
- endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
- ribosomal small subunit biogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA 3'-terminal phosphate cyclase
- RNA 3'-terminal phosphate cyclase, insert domain
- RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta
- RNA 3'-terminal phosphate cyclase-like, conserved site
- RNA 3'-terminal phosphate cyclase domain
- RNA 3'-terminal phosphate cyclase, insert domain superfamily
- RNA 3'-terminal phosphate cyclase domain superfamily
- RNA 3'-terminal phosphate cyclase
- RNA 3'-terminal phosphate cyclase (RTC), insert domain
- RNA 3'-terminal phosphate cyclase type 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RCL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RCL1 as an antibody target. Whether an autoantibody or antibody against RCL1 could matter depends on whether native RCL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RCL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RCL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...